{"id":"autologous-bone-marrow-stem-cell","safety":{"commonSideEffects":[{"rate":"10-30%","effect":"Bone marrow suppression"},{"rate":"5-20%","effect":"Infection"},{"rate":"5-15%","effect":"Nausea and vomiting"}]},"_chembl":{"chemblId":"CHEMBL5315099","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process typically involves collecting the patient's bone marrow stem cells, processing them to remove any diseased cells, and then reinfusing them into the patient's body. The goal is to stimulate the growth of new bone tissue, which can help to repair damaged or diseased bone.","oneSentence":"Autologous bone marrow stem cell therapy involves using a patient's own stem cells to stimulate the growth of new bone tissue.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:29:44.829Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of multiple myeloma and other hematologic malignancies"}]},"trialDetails":[{"nctId":"NCT02443077","phase":"PHASE3","title":"Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-10-12","conditions":"Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type","enrollment":94},{"nctId":"NCT04975698","phase":"PHASE2","title":"HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903","status":"COMPLETED","sponsor":"Catherine Bollard","startDate":"2021-10-25","conditions":"HIV Associated Lymphoma","enrollment":12},{"nctId":"NCT04268498","phase":"PHASE2","title":"A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2020-02-11","conditions":"Multiple Myeloma","enrollment":310},{"nctId":"NCT06576583","phase":"PHASE2","title":"Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-15","conditions":"Patellofemoral Osteoarthritis","enrollment":150},{"nctId":"NCT03267433","phase":"PHASE3","title":"Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2017-11-27","conditions":"Mantle Cell Lymphoma","enrollment":689},{"nctId":"NCT04749667","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-08-09","conditions":"Multiple Sclerosis, Progressive Multiple Sclerosis","enrollment":18},{"nctId":"NCT07458854","phase":"NA","title":"Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2014-10-14","conditions":"Hematologic Malignacy, Autologous Hematopoietic Stem Cell Transplantation","enrollment":15},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT00716066","phase":"PHASE2","title":"Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2008-06","conditions":"Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune","enrollment":53},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT07431008","phase":"","title":"Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction","status":"RECRUITING","sponsor":"Pharmicell Co., Ltd.","startDate":"2024-12-26","conditions":"Erectile Dysfunction","enrollment":32},{"nctId":"NCT05432635","phase":"PHASE1","title":"Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-08-01","conditions":"B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma","enrollment":15},{"nctId":"NCT06207799","phase":"PHASE2","title":"Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-07-17","conditions":"Multiple Myeloma, Post-transplant MRD-guided Maintenance Therapy, Pre-transplant Purging","enrollment":40},{"nctId":"NCT05393804","phase":"PHASE2","title":"A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-05-20","conditions":"Multiple Myeloma","enrollment":32},{"nctId":"NCT04594850","phase":"PHASE2","title":"Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2020-10-19","conditions":"Erectile Dysfunction","enrollment":54},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT07392970","phase":"PHASE2","title":"Motixafortide for MRD Sensitization in AML","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-03-31","conditions":"Acute Myeloid Leukemia, Measurable Residual Disease","enrollment":10},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT07386548","phase":"NA","title":"Biologic Injection For Adults With Lumbar Disc Herniation","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-01","conditions":"Degenerative Disc Disease, DDD, Degenerative Disc Disease Lumbar","enrollment":90},{"nctId":"NCT06647979","phase":"PHASE1","title":"Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies","status":"RECRUITING","sponsor":"Daniel Bauer","startDate":"2025-12-01","conditions":"Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Beta-Thalassemia","enrollment":10},{"nctId":"NCT01736059","phase":"PHASE1","title":"Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Davis","startDate":"2012-07","conditions":"Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion","enrollment":15},{"nctId":"NCT02659215","phase":"NA","title":"HyaloFAST Trial for Repair of Articular Cartilage in the Knee","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anika Therapeutics, Inc.","startDate":"2015-12","conditions":"Defect of Articular Cartilage","enrollment":200},{"nctId":"NCT07365306","phase":"PHASE2","title":"Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-12-30","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent Primary Mediastinal Large B-Cell Lymphoma","enrollment":43},{"nctId":"NCT03282656","phase":"PHASE1","title":"Gene Transfer for Sickle Cell Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Williams","startDate":"2018-02-13","conditions":"Sickle Cell Disease","enrollment":10},{"nctId":"NCT06692452","phase":"PHASE2","title":"Tazemetostat Plus CHOP in 1L T-cell Lymphoma","status":"SUSPENDED","sponsor":"Eric Jacobsen, MD","startDate":"2024-12-24","conditions":"Lymphoma, Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma","enrollment":24},{"nctId":"NCT05711849","phase":"PHASE2","title":"Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina","status":"RECRUITING","sponsor":"Barts & The London NHS Trust","startDate":"2024-03-01","conditions":"Refractory Angina Pectoris, Refractory Angina","enrollment":110},{"nctId":"NCT04650568","phase":"NA","title":"Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction","status":"ENROLLING_BY_INVITATION","sponsor":"Rush University Medical Center","startDate":"2017-11-03","conditions":"Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture","enrollment":100},{"nctId":"NCT03455725","phase":"NA","title":"CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioCardia, Inc.","startDate":"2021-06-30","conditions":"Refractory Angina, Chronic Myocardial Ischemia","enrollment":343},{"nctId":"NCT07066228","phase":"NA","title":"Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xinxiang Medical College","startDate":"2025-08-07","conditions":"Defective Composite Restorations, Bone Cysts, Bone Defect","enrollment":30},{"nctId":"NCT04745221","phase":"NA","title":"Efficacy and Safety of Auto-FMT in Preventing aGVHD","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-03-01","conditions":"Graft Versus Host Disease, Acute","enrollment":100},{"nctId":"NCT01850888","phase":"NA","title":"MIBG for Refractory Neuroblastoma and Pheochromocytoma","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2013-12","conditions":"Relapsed Neuroblastoma, Metastatic Pheochromocytoma","enrollment":15},{"nctId":"NCT06910384","phase":"PHASE2","title":"A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)","status":"TERMINATED","sponsor":"New England Cell Therapeutics, Inc.","startDate":"2025-08-12","conditions":"Amyotrophic Lateral Sclerosis","enrollment":1},{"nctId":"NCT01794572","phase":"NA","title":"Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse","status":"TERMINATED","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2013-04-09","conditions":"Multiple Myeloma in Relapse","enrollment":13},{"nctId":"NCT01560182","phase":"PHASE1, PHASE2","title":"Gene Therapy for Metachromatic Leukodystrophy (MLD)","status":"COMPLETED","sponsor":"Orchard Therapeutics","startDate":"2010-04-09","conditions":"Lysosomal Storage Disease, Metachromatic Leukodystrophy","enrollment":20},{"nctId":"NCT00534469","phase":"PHASE2","title":"Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2000-02-08","conditions":"Leukemia","enrollment":60},{"nctId":"NCT07188090","phase":"PHASE2","title":"Mozobil for Autologous Hematopoietic Stem Cell Transplantation","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-10-16","conditions":"Multiple Myeloma, Hodgkin Lymphoma, Non-hodgkin Lymphoma","enrollment":100},{"nctId":"NCT05052957","phase":"PHASE2","title":"hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)","status":"RECRUITING","sponsor":"Leland Metheny","startDate":"2023-01-20","conditions":"Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma","enrollment":16},{"nctId":"NCT01512888","phase":"PHASE1, PHASE2","title":"Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants","status":"SUSPENDED","sponsor":"St. Jude Children's Research Hospital","startDate":"2016-08-17","conditions":"Severe Combined Immunodeficiency Disease, X-linked","enrollment":28},{"nctId":"NCT03219359","phase":"PHASE2","title":"Autologous Stem Cell Transplant for Crohn's Disease","status":"RECRUITING","sponsor":"Aaron Etra","startDate":"2018-02-22","conditions":"Crohn Disease","enrollment":50},{"nctId":"NCT03630211","phase":"PHASE2","title":"Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2018-07-31","conditions":"Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease","enrollment":8},{"nctId":"NCT04735185","phase":"NA","title":"Stem Cells vs. Steroids for Discogenic Back Pain","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2025-09-30","conditions":"Chronic Low Back Pain, Degenerative Disc Disease","enrollment":""},{"nctId":"NCT07205523","phase":"","title":"High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)","status":"RECRUITING","sponsor":"Yigeng Cao,MD,PhD","startDate":"2023-09-01","conditions":"Hematopoietic Stem Cell Transplantation (HSCT), Acute Myeloid Leukemia (AML), Leukemias, Acute Myeloid","enrollment":1000},{"nctId":"NCT01071577","phase":"","title":"Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2010-03-17","conditions":"Bone Marrow Stromal Cells","enrollment":65},{"nctId":"NCT03477942","phase":"PHASE1","title":"Impact of Mesenchymal Stem Cells in Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2018-10-01","conditions":"Musculoskeletal Pain, Knee Osteoarthritis, Cartilage Injury","enrollment":16},{"nctId":"NCT01740869","phase":"PHASE3","title":"Autologous Bone Marrow Stem Cells for Children With Autism Spectrum Disorders","status":"COMPLETED","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2012-11","conditions":"Autism, Autism Spectrum","enrollment":30},{"nctId":"NCT06022939","phase":"PHASE3","title":"Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2024-07-01","conditions":"AL Amyloidosis","enrollment":338},{"nctId":"NCT04042844","phase":"PHASE2","title":"A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)","status":"RECRUITING","sponsor":"BioRestorative Therapies","startDate":"2022-06-30","conditions":"Lumbar Disc Disease","enrollment":99},{"nctId":"NCT03822858","phase":"","title":"Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis","status":"AVAILABLE","sponsor":"Tisch Multiple Sclerosis Research Center of New York","startDate":"","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT07101562","phase":"NA","title":"Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Avascular Necrosis of Femur Head","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xinxiang Medical College","startDate":"2025-07-30","conditions":"Avascular Necrosis of Femur Head","enrollment":30},{"nctId":"NCT05925036","phase":"PHASE1","title":"Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-01","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":40},{"nctId":"NCT07094100","phase":"NA","title":"Tissue Engineered Cartilage to Repairing Articular Cartilage Defects","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xinxiang Medical College","startDate":"2025-07-20","conditions":"Cartilage Injury, OA Knee","enrollment":30},{"nctId":"NCT06205342","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-07-17","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":48},{"nctId":"NCT03572660","phase":"PHASE2","title":"Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM","status":"RECRUITING","sponsor":"Barts & The London NHS Trust","startDate":"2018-12-24","conditions":"Dilated Cardiomyopathy","enrollment":20},{"nctId":"NCT02924571","phase":"NA","title":"BMAC & Allograft vs BMP-2","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2018-07-24","conditions":"Spinal Fusion","enrollment":59},{"nctId":"NCT03355365","phase":"PHASE2","title":"Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Tisch Multiple Sclerosis Research Center of New York","startDate":"2018-09-21","conditions":"Multiple Sclerosis","enrollment":54},{"nctId":"NCT02795052","phase":"NA","title":"Neurologic Stem Cell Treatment Study","status":"RECRUITING","sponsor":"MD Stem Cells","startDate":"2016-06","conditions":"Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases","enrollment":500},{"nctId":"NCT06997939","phase":"PHASE1, PHASE2","title":"Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2025-06-01","conditions":"Ischemic Stroke","enrollment":12},{"nctId":"NCT05066334","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2021-03-22","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":52},{"nctId":"NCT04759105","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2019-11-03","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":48},{"nctId":"NCT03490344","phase":"PHASE2","title":"Short Course Daratumumab in Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-05-03","conditions":"Multiple Myeloma","enrollment":10},{"nctId":"NCT01044069","phase":"PHASE1","title":"Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2010-01-05","conditions":"Leukemia, Acute Lymphoblastic Leukemia","enrollment":93},{"nctId":"NCT01515462","phase":"PHASE1, PHASE2","title":"Gene Therapy for Wiskott-Aldrich Syndrome","status":"COMPLETED","sponsor":"Fondazione Telethon","startDate":"2010-04-20","conditions":"Wiskott-Aldrich Syndrome (WAS)","enrollment":8},{"nctId":"NCT02582489","phase":"NA","title":"Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2017-12-22","conditions":"Osteoarthritis Post-meniscectomy","enrollment":100},{"nctId":"NCT05947175","phase":"NA","title":"Vertebral Bone Marrow Clot for Spinal Surgery","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-05-19","conditions":"Degenerative Spine Diseases","enrollment":96},{"nctId":"NCT00638898","phase":"PHASE1","title":"Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2007-02-26","conditions":"Solid Tumor, Adult Central Nervous System Germ Cell Tumor, Adult Rhabdomyosarcoma","enrollment":25},{"nctId":"NCT02140554","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease","status":"COMPLETED","sponsor":"Genetix Biotherapeutics Inc.","startDate":"2015-02-02","conditions":"Sickle Cell Disease","enrollment":54},{"nctId":"NCT06581081","phase":"NA","title":"Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-10-01","conditions":"Relapsed Adult ALL, B-cell Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":130},{"nctId":"NCT06858254","phase":"PHASE1, PHASE2","title":"Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism","status":"NOT_YET_RECRUITING","sponsor":"Apeiron Research Center","startDate":"2025-04-01","conditions":"Atypical Parkinsonism, Parkinson Disease (PD)","enrollment":60},{"nctId":"NCT05507099","phase":"PHASE2","title":"Stem Cell Study in Osteoarthritis of the Knee and Hip Joints","status":"RECRUITING","sponsor":"Grigory Karmy","startDate":"2022-08-23","conditions":"Osteoarthritis","enrollment":400},{"nctId":"NCT06822686","phase":"NA","title":"Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2025-03-01","conditions":"Fistula in Ano, Crohn Disease","enrollment":10},{"nctId":"NCT00554788","phase":"PHASE3","title":"Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-05-06","conditions":"Extraocular Retinoblastoma","enrollment":60},{"nctId":"NCT04745299","phase":"PHASE3","title":"Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corestemchemon, Inc.","startDate":"2021-03-23","conditions":"Amyotrophic Lateral Sclerosis","enrollment":115},{"nctId":"NCT03002207","phase":"NA","title":"Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Zhanghao","startDate":"2016-10","conditions":"Lumbar Disc Herniation","enrollment":25},{"nctId":"NCT02863926","phase":"PHASE1","title":"Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)","status":"COMPLETED","sponsor":"Michael Murphy","startDate":"2017-01-06","conditions":"Peripheral Artery Disease, Vascular Disease, Critical Limb Ischemia","enrollment":6},{"nctId":"NCT03546556","phase":"EARLY_PHASE1","title":"18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients","status":"TERMINATED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2017-01-01","conditions":"Graft Vs Host Disease","enrollment":10},{"nctId":"NCT06724237","phase":"PHASE3","title":"Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy","status":"NOT_YET_RECRUITING","sponsor":"Eastern Cooperative Oncology Group","startDate":"2024-12-01","conditions":"Anaplastic Large Cell Lymphoma, ALK-Negative, Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type","enrollment":294},{"nctId":"NCT03325504","phase":"PHASE3","title":"A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2017-09-05","conditions":"Non Union Fracture","enrollment":46},{"nctId":"NCT03981549","phase":"PHASE1, PHASE2","title":"Treatment of Central Retinal Vein Occlusion Using Stem Cells Study","status":"COMPLETED","sponsor":"The Emmes Company, LLC","startDate":"2019-10-22","conditions":"Central Retinal Vein Occlusion","enrollment":16},{"nctId":"NCT05086939","phase":"PHASE3","title":"Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","startDate":"2021-05-26","conditions":"Knee Osteoarthritis","enrollment":124},{"nctId":"NCT06676423","phase":"PHASE1","title":"Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS","status":"COMPLETED","sponsor":"Corestemchemon, Inc.","startDate":"2022-11-09","conditions":"Amyotrophic Lateral Sclerosis","enrollment":8},{"nctId":"NCT03265444","phase":"PHASE1","title":"Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy","status":"COMPLETED","sponsor":"Corestemchemon, Inc.","startDate":"2018-04-13","conditions":"Multiple System Atrophy","enrollment":9},{"nctId":"NCT06636643","phase":"","title":"The Effect of Bone Marrow Stem Cells Harvested from the Iliac Crest Versus Mandibular Ramus in Alveolar Cleft Regeneration","status":"COMPLETED","sponsor":"Faculty of Dental Medicine for Girls","startDate":"2021-04-15","conditions":"Cleft Lip and Palate","enrollment":12},{"nctId":"NCT04925687","phase":"PHASE1","title":"Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2021-06-01","conditions":"Retinitis Pigmentosa","enrollment":4},{"nctId":"NCT04080921","phase":"PHASE1, PHASE2","title":"Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2014-06-16","conditions":"Encephalitis, Meningitis","enrollment":22},{"nctId":"NCT03343782","phase":"PHASE1, PHASE2","title":"Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2017-11-01","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT03468699","phase":"PHASE2","title":"Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2017-01-02","conditions":"Liver Cirrhosis, Biliary","enrollment":17},{"nctId":"NCT02525432","phase":"PHASE2","title":"Autologous Stem Cell Study for Adult TBI (Phase 2b)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-11-21","conditions":"Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury)","enrollment":37},{"nctId":"NCT02728102","phase":"PHASE2","title":"Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2016-07","conditions":"Multiple Myeloma","enrollment":203},{"nctId":"NCT06400862","phase":"PHASE1","title":"Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-02-26","conditions":"Traumatic Cartilage Injury","enrollment":9},{"nctId":"NCT02186418","phase":"PHASE1, PHASE2","title":"Gene Transfer for Patients With Sickle Cell Disease","status":"TERMINATED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-07","conditions":"Anemia, Sickle Cell","enrollment":7},{"nctId":"NCT00596154","phase":"PHASE2","title":"Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-12","conditions":"CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma","enrollment":33},{"nctId":"NCT04689152","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis","status":"RECRUITING","sponsor":"Pharmicell Co., Ltd.","startDate":"2021-03-02","conditions":"Alcoholic Cirrhosis","enrollment":200},{"nctId":"NCT03157804","phase":"PHASE1, PHASE2","title":"Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A","status":"COMPLETED","sponsor":"Hospital Infantil Universitario Niño Jesús, Madrid, Spain","startDate":"2016-01-07","conditions":"Fanconi Anemia","enrollment":9},{"nctId":"NCT01328860","phase":"PHASE1","title":"Autologous Stem Cells for Spinal Cord Injury (SCI) in Children","status":"TERMINATED","sponsor":"Aryn Knight","startDate":"2011-04","conditions":"Spinal Cord Injury","enrollment":10},{"nctId":"NCT06308133","phase":"","title":"Biological Variables Affecting CD34+ Peripheral Cells Collection Efficiency","status":"COMPLETED","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2023-09-01","conditions":"Optimize PBSC Harvest Through Automated Buffy Coat","enrollment":113},{"nctId":"NCT03280056","phase":"PHASE3","title":"Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients","status":"COMPLETED","sponsor":"Brainstorm-Cell Therapeutics","startDate":"2017-08-28","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":196},{"nctId":"NCT01505569","phase":"NA","title":"Auto Transplant for High Risk or Relapsed Solid or CNS Tumors","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2011-10-20","conditions":"Ewing's Family Tumors, Renal Tumors, Hepatoblastoma","enrollment":44},{"nctId":"NCT06267781","phase":"","title":"RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2022-09-02","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT03478670","phase":"","title":"Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)","status":"ENROLLING_BY_INVITATION","sponsor":"Fondazione Telethon","startDate":"2017-03-28","conditions":"Immunologic Deficiency Syndromes","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":102,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Autologous bone marrow stem cell","genericName":"Autologous bone marrow stem cell","companyName":"Manipal Acunova Ltd.","companyId":"manipal-acunova-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Autologous bone marrow stem cell therapy involves using a patient's own stem cells to stimulate the growth of new bone tissue. Used for Treatment of multiple myeloma and other hematologic malignancies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}